Skeletal muscle dysfunction in chronic obstructive pulmonary disease

Respiratory Medicine: COPD Update

Volumn 5, Issue 1, 2009, Pages 7-13

  Shrikrishna, Dinesh ^a   Hopkinson, Nicholas S ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Magnetic stimulation; Pulmonary rehabilitation; Quadriceps; Therapy

Indexed keywords

ACETYLCYSTEINE; GROWTH HORMONE; NANDROLONE; TESTOSTERONE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIET THERAPY; ELECTROSTIMULATION THERAPY; EXERCISE; HUMAN; MORTALITY; MUSCLE MASS; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYOPATHY; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUADRICEPS FEMORIS MUSCLE; QUALITY OF LIFE; REVIEW; SKELETAL MUSCLE;

EID: 61749089076     PISSN: 17450454     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmedu.2009.01.002     Document Type: Review

References (90)

1. Celli B.R., MacNee W., Agusti A., Berg B., Buist A.S., et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
2. American Thoracic Society/European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 159 (1999) S1-40
3. Jones P.W. Health status measurement in chronic obstructive pulmonary disease. Thorax 56 (2001) 880-887
4. Fowler J., and Godlee R. Diseases of the Lungs (1898), Green and Co, London, Longmans
5. Engelen M.P., Schols A.M., Baken W.C., Wesseling G.J., and Wouters E.F. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 7 (1994) 1793-1797
6. Schols A.M., Soeters P.B., Dingemans A.M., Mostert R., Frantzen P.J., and Wouters E.F. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 147 (1993) 1151-1156
7. Wilson D.O., Rogers R.M., Wright E.C., and Anthonisen N.R. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 139 (1989) 1435-1438
8. Boushy S.F., Adhikari P.K., Sakamoto A., and Lewis B.M. Factors Affecting Prognosis in Emphysema. Dis Chest 45 (1964) 402-411
9. Vandenbergh E., Van de Woestijne K.P., and Gyselen A. Weight changes in the terminal stages of chronic obstructive pulmonary disease. Relation to respiratory function and prognosis. Am Rev Respir Dis 95 (1967) 556-566
10. Prescott E., Almdal T., Mikkelsen K.L., Tofteng C.L., Vestbo J., and Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 20 (2002) 539-544
11. Landbo C., Prescott E., Lange P., Vestbo J., and Almdal T.P. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) 1856-1861
12. Gray-Donald K., Gibbons L., Shapiro S.H., Macklem P.T., and Martin J.G. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 153 (1996) 961-966
13. Celli B.R., Cote C.G., Marin J.M., Casanora C., Montes de Oca M., Mendez R.A., et al. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. The New England journal of medicine 350 (2004) 1005-1012
14. Marti S., Munoz X., Rios J., Morell F., and Ferrer J. Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur Respir J 27 (2006) 689-696
15. Chailleux E., Laaban J.-P., and Veale D. Prognostic Value of Nutritional Depletion in Patients With COPD Treated by Long-term Oxygen Therapy: Data From the ANTADIR Observatory. Chest 123 (2003) 1460-1466
16. Cano N.J.M., Pichard C., Roth H., Court-fortune I., Cynober L., Gerard-Boncompain M., et al. C-Reactive Protein and Body Mass Index Predict Outcome in End-Stage Respiratory Failure. Chest 126 (2004) 540-546
17. Schols A.M., Slangen J., Volovics L., and Wouters E.F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1791-1797
18. Mostert R., Goris A., Weling-Scheepers C., Wouters E.F., and Schols A.M. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 94 (2000) 859-867
19. Shoup R., Dalsky G., Warner S., Davies M., Connors M., Khan M., et al. Body composition and health-related quality of life in patients with obstructive airways disease. Eur Respir J 10 (1997) 1576-1580
20. Hamilton A.L., Killian K.J., Summers E., and Jones N.L. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 152 (1995) 2021-2031
21. Gosselink R., Troosters T., and Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 153 (1996) 976-980
22. Bernard S., LeBlanc P., Whittom F., Carrier G., Jobin J., Belleau R., et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158 (1998) 629-634
23. Man W.D.-C., Soliman M.G.G., Gearing J., Radford S.G., Rafferty G.F., Gray B.J., et al. Symptoms and Quadriceps Fatigability after Walking and Cycling in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 168 (2003) 562-567
24. Killian K.J., Leblanc P., Martin D.H., Summers E., Jones N.L., and Campbell E.J. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 146 (1992) 935-940
25. Saey D., Debigare R., LeBlanc P., Mador M.J., Cote C.H., Jobin J., et al. Contractile Leg Fatigue after Cycle Exercise: A Factor Limiting Exercise in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 168 (2003) 425-430
26. Gea J., Orozco-Levi M., Barreiro E., Ferrer A., and Broquetas J. Structural and functional changes in the skeletal muscles of COPD patients: the "compartments" theory. Monaldi Arch Chest Dis 56 (2001) 214-224
27. Man W.D., Soliman M.G., Nikoletou D., Harris M.L., Rafferty G.F., Mustfa N., et al. Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax 58 (2003) 665-669
28. Man W.D., Hopkinson N.S., Harraf F., Nikoletou D., Polkey M.I., and Moxham J. Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease. Thorax 60 (2005) 718-722
29. Hopkinson N.S., Nickol A.H., Payne J., Hawe E., Man W.D., Moxham J., et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170 (2004) 395-399
30. Swallow E.B., Reyes D., Hopkinson N.S., Man W.D., Porcher R., Cetti E.J., et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 62 (2007) 115-120
31. Simpson K., Killian K., McCartney N., Stubbing D.G., and Jones N.L. Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax 47 (1992) 70-75
32. Decramer M., Gosselink R., Troosters T., Verschueren M., and Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 10 (1997) 417-423
33. Coronell C., Orozco-Levi M., Mendez R., Ramirez-Sarmiento A., Galdiz J.B., and Gea J. Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J 24 (2004) 129-136
34. Swallow E.B., Gosker H.R., Ward K.A., Moore A.J., Dayer M.J., Hopkinson N.S., et al. A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans. J Appl Physiol 103 (2007) 739-746
35. Hopkinson N.S., Eleftheriou K.I., Payne J., Nickol A.H., Hawe E., Moxham J., et al. +9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 83 (2006) 912-917
36. Hopkinson N.S., Li K.W., Kehoe A., Humphries S.E., Roughton M., Moxham J., et al. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. The American journal of clinical nutrition 87 (2008) 385-390
37. Pitta F., Troosters T., Spruit M.A., Probst V.S., Decramer M., and Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 (2005) 972-977
38. Kortebein P., Ferrando A., Lombeida J., Wolfe R., and Evans W.J. Effect of 10 Days of Bed Rest on Skeletal Muscle in Healthy Older Adults. JAMA 297 (2007) 1772-a-1774
39. Harris M.L., Polkey M.I., Bath P.M., and Moxham J. Quadriceps muscle weakness following acute hemiplegic stroke. Clin Rehabil 15 (2001) 274-281
40. Spruit M.A., Gosselink R., Troosters T., Kasran A., Gayan-Ramirez G., Bogaerts P., et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 58 (2003) 752-756
41. Gosker H.R., Kubat B., Schaart G., van der Vusse G.J., Wouters E.F., and Schols A.M. Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease. Eur Respir J 22 (2003) 280-285
42. Gosker H.R., Zeegers M.P., Wouters E.F., and Schols A.M. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 62 (2007) 944-949
43. Jakobsson P., Jorfeldt L., and Brundin A. Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 3 (1990) 192-196
44. Jobin J., Maltais F., Doyon J.F., LeBlanc P., Simard P.M., Simard A., et al. Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. J Cardiopulm Rehabil 18 (1998) 432-437
45. Gea J.G., Pasto M., Carmona M.A., Orozco-Levi M., Palomeque J., and Broquetas J. Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J 17 (2001) 939-945
46. Levine S., Kaiser L., Leferovich J., and Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 337 (1997) 1799-1806
47. Gan W.Q., Man S.F.P., Senthilselvan A., and Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59 (2004) 574-580
48. Di Francia M., Barbier D., Mege J.L., and Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150 (1994) 1453-1455
49. Fekete A., Rosta K., Wagner L., Prokai A., Degrell P., Ruzieska E., et al. Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney - another reason for diabetic nephropathy?. J Physiol 586 (2008) 5337-5348
50. Barreiro E., Schols A.M.W.J., Polkey M.I., Galdiz J.B., Gosker H.R., Swallow E.B., et al. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 63 (2008) 100-107
51. Rabinovich R.A., Ardite E., Mayer A.M., Polo M.F., Vilaro J., Argiles J.M., et al. Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index. Respiration 73 (2006) 757-761
52. Barreiro E, Rabinovich RA, Marin J, Barbera JA, Gea J, Roca J: Chronic Endurance Exercise Induces Quadriceps Nitrosative Stress In Severe Copd Patients. Thorax. DOI: thx.2008.105163 [pii] 10.1136/thx.2008.105163.
53. Radom-Aizik S., Kaminski N., Hayek S., Halkin H., Cooper D.M., and Ben-Dov I. Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease. J Appl Physiol 102 (2007) 1976-1984
54. Couillard A., and Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J 26 (2005) 703-719
55. Decramer M., de Bock V., and Dom R. Functional and histologic picture of steroid-induced myopathy in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 153 (1996) 1958-1964
56. Hopkinson N.S., Man W.D., Dayer M.J., Ross E.T., Nickol A.H., Hart N., et al. Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease. Eur Respir J 24 (2004) 137-142
57. Schols A.M., Wesseling G., Kester A.D., de Vries G., Mostert R., Slangen J., et al. Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. Eur Respir J 17 (2001) 337-342
58. Di Stefano A., Caramori G., Oates T., Capelli A., Lusuarai M., Gnemmi I., et al. Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J 20 (2002) 556-563
59. Ito K., Ito M., Elliott W.M., Cosio B., Caramori G., Kon O.M., et al. Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease. N Engl J Med 352 (2005) 1967-1976
60. Cai D., Frantz J.D., Tawa Jr. N.E., Melendez P.A., Oh B.C., Lidor H.G., et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119 (2004) 285-298
61. Agusti A., Morla M., Sauleda J., Saus C., and Busquets X. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 59 (2004) 483-487
62. Doucet M., Russell A.P., Leger B., Debigare R., Joanisse D.R., Caron M.A., et al. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 176 (2007) 261-269
63. Ottenheijm C.A., Heunks L.M., and Dekhuijzen R.P. Diaphragm adaptations in patients with COPD. Respiratory research 9 (2008) 12
64. Luquet S., Lopez-Soriano J., Holst D., Fredenrich A., Melki J., Rassoulzadegan M., et al. Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. Faseb J 17 (2003) 2299-2301
65. Remels A.H., Schrauwen P., Broekhuizen R., Willems J., Kersten S., Gosker H.R., et al. Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD. Eur Respir J 30 (2007) 245-252
66. Sathyapala S.A., Kemp P., and Polkey M.I. Decreased muscle PPAR concentrations: a mechanism underlying skeletal muscle abnormalities in COPD?. Eur Respir J 30 (2007) 191-193
67. Hopkinson N.S., Tennant R.C., Dayer M.J., Swallow E.B., Hansel T.T., Moxham J., et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 8 (2007) 25
68. Schols A.M., Wouters E.F., Soeters P.B., and Westerterp K.R. Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 53 (1991) 421-424
69. Martin H.J., Yule V., Syddall H.E., Dennison E.M., Cooper C., and Aihie Sayer A. Is hand-held dynamometry useful for the measurement of quadriceps strength in older people? A comparison with the gold standard Biodex dynamometry. Gerontology 52 (2006) 154-159
70. O'Shea S.D., Taylor N.F., and Paratz J.D. Measuring muscle strength for people with chronic obstructive pulmonary disease: retest reliability of hand-held dynamometry. Archives of physical medicine and rehabilitation 88 (2007) 32-36
71. Edwards R.H., Young A., Hosking G.P., and Jones D.A. Human skeletal muscle function: description of tests and normal values. Clin Sci Mol Med 52 (1977) 283-290
72. Man W.D.C., Moxham J., and Polkey M.I. Magnetic stimulation for the measurement of respiratory and skeletal muscle function. Eur Respir J 24 (2004) 846-860
73. Polkey M.I., Kyroussis D., Hamnegard C.H., Mills G.H., Green M., and Moxham J. Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man. Muscle Nerve 19 (1996) 549-555
74. Degens H., Sanchez Horneros J.M., Heijdra Y.F., Dekhuijzen P.N., and Hopman M.T. Skeletal muscle contractility is preserved in COPD patients with normal fat-free mass. Acta Physiol Scand 184 (2005) 235-242
75. Wust R.C., Morse C.I., de Haan A., Rittweger J., Jones D.A., and Degens H. Skeletal muscle properties and fatigue resistance in relation to smoking history. European journal of applied physiology 104 (2008) 103-110
76. Ambrosino N., and Strambi S. New strategies to improve exercise tolerance in chronic obstructive pulmonary disease. Eur Respir J 24 (2004) 313-322
77. Casaburi R. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Med Sci Sports Exerc 33 (2001) S662-S670
78. Nici L., Donner C., Wouters E., Zuwallack R., Ambrosino N., Bourbeau J., et al. American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation. Am J Respir Crit Care Med 173 (2006) 1390-1413
79. Troosters T., Gosselink R., and Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. The American journal of medicine 109 (2000) 207-212
80. Creutzberg E.C., Wouters E.F.M., and Mostert R. Weling-Scheepers CAPM, Schols AMWJ: Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition 19 (2003) 120-127
81. Ferreira I.M., Brooks D., Lacasse Y., Goldstein R.S., and White J. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane database of systematic reviews (Online) (2005) CD000998
82. Deacon S.J., Vincent E.E., Greenhaff P.L., Fox J., Steiner M.C., Singh S.J., et al. Randomized Controlled Trial of Dietary Creatine as an Adjunct Therapy to Physical Training in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 178 (2008) 233-239
83. Casaburi R., Bhasin S., Cosentino L., Porszasz J. Somfay A., Lewis M.I., et al. Effects of Testosterone and Resistance Training in Men with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 170 (2004) 870-878
84. Lewis M.I., Fournier M., Storer T.W., Bhasin S., Porszasz J., Ren S.-G., et al. Skeletal muscle adaptations to testosterone and resistance training in men with COPD. J Appl Physiol 103 (2007) 1299-1310
85. Burdet L., de Muralt B., Schutz Y., Pichard C., and Fitting J.W. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med 156 (1997) 1800-1806
86. Creutzberg E.C., Wouters E.F.M., Mostert R., and Pluymers R.J. Schols AMWJ: A Role for Anabolic Steroids in the Rehabilitation of Patients With COPD?: A Double-Blind, Placebo-Controlled, Randomized Trial. Chest 124 (2003) 1733-1742
87. Bourjeily-Habr G., Rochester C.L., Palermo F., Snyder P., and Mohsenin V. Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease. Thorax 57 (2002) 1045-1049
88. Vivodtzev I., Pepin J.-L., Vottero G., Mayer V., Porsin B., Levy P., et al. Improvement in Quadriceps Strength and Dyspnea in Daily Tasks After 1 Month of Electrical Stimulation in Severely Deconditioned and Malnourished COPD. Chest 129 (2006) 1540-1548
89. Koechlin C., Couillard A., Simar D., Cristol J.P., Bellet H., Hayot M., et al. Does Oxidative Stress Alter Quadriceps Endurance in Chronic Obstructive Pulmonary Disease?. Am J Respir Crit Care Med 169 (2004) 1022-1027
90. Goodyear L.J. The exercise pill-too good to be true?. The New England journal of medicine 359 (2008) 1842-1844